{"SPADE_N_15397": {"Sequence Information": {"Peptide Name": "Lantibiotic Cinnamycin, Ro 09-0198", "Sequence": "CRQSCXFGPFTFVCXGNTK", "Sequence Length": 19, "Biological Activity": ["Anti-Gram+", "Antiviral", "Anticancer", "Anti-Mammalian Cell"], "Binding Target": "1. Membrane Protein", "Source": "1. Streptomyces cinnamoneus\n2. Streptomyces griseoverticillatus", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "P29827", "uniprotUrl": "http://www.uniprot.org/uniprot/P29827", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}], "Literature": [{"Title": "Duramycins B and C, two new lanthionine containing antibiotics as inhibitors of phospholipase A2. Structural revision of duramycin and cinnamycin", "Pubmed ID": "2125590", "Reference": "J Antibiot (Tokyo). 1990;43:1403-1412", "Author": "Fredenhagen A, Fendrich G, Märki F, Märki W, Gruner J, Raschdorf F, Peter HH", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/2125590"}, {"Title": "Labyrinthopeptins Exert Broad-Spectrum Antiviral Activity through Lipid-Binding-Mediated Virolysis.", "Pubmed ID": "31666384", "Reference": "J Virol. 2020;94:e01471-19", "Author": "Prochnow H, Rox K, Birudukota NVS, Weichert L, Hotop SK, Klahn P, Mohr KI, Franz S, Banda DH, et al.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/31666384"}], "SPADE ID": "SPADE_N_15397", "Similar Sequences": [{"SPADE_ID": "SPADE_N_00050", "Similarity": 1.0, "Sequence": "CRQSCSFGPFTFVCDGNTK"}, {"SPADE_ID": "SPADE_N_06055", "Similarity": 1.0, "Sequence": "MTASILQQSVVDADFRAALLENPAAFGASAAALPTPVEAQDQASLDFWTKDIAATEAFACRQSCSFGPFTFVCDGNTK"}, {"SPADE_ID": "SPADE_N_15048", "Similarity": 0.9411764705882353, "Sequence": "CRQSCFGPLTFVCGNTK"}], "Hemolytic Activity": "Chinese hamster ovary cells CHO:50% Cytotoxicity=28.4 µg/ml", "Target Organism": "Bacillus subtilis(MIC=0.78µg/ml),Human hepatocellular carcinoma HepG2(50-60% Cytotoxicity=26.1µg/ml),DENV-2(no activity data)"}}}